1. BET bromodomain inhibitor HMBA synergizes with MEK inhibition in treatment of malignant glioma. Issue 1 (2nd January 2021) Authors: Funck-Brentano, Elisa; Vizlin-Hodzic, Dzeneta; Nilsson, Jonas A.; Nilsson, Lisa M. Journal: Epigenetics Issue: Volume 16:Issue 1(2021) Page Start: 54 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Clinical, genetic and experimental studies of the Brooke–Spiegler (CYLD) skin tumor syndrome. Issue 2 (4th March 2019) Authors: Andersson, Mattias K.; Kölby, Lars; Nilsson, Jonas A.; Stenman, Göran Journal: Journal of plastic surgery and hand surgery Issue: Volume 53:Issue 2(2019) Page Start: 71 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Mouse avatars take off as cancer models. (11th October 2018) Authors: Nilsson, Jonas A.; Olofsson Bagge, Roger; Ny, Lars Journal: Nature Issue: Volume 562:Number 7726(2018) Page Start: 192 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Pathogenesis and therapeutic targeting of aberrant MYC expression in haematological cancers. (24th November 2017) Authors: Schick, Markus; Habringer, Stefan; Nilsson, Jonas A.; Keller, Ulrich Journal: British journal of haematology Issue: Volume 179:Number 5(2017) Page Start: 724 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. RNAi delivery by exosome-mimetic nanovesicles – Implications for targeting c-Myc in cancer. (September 2016) Authors: Lunavat, Taral R.; Jang, Su Chul; Nilsson, Lisa; Park, Hyun Taek; Repiska, Gabriela; Lässer, Cecilia; Nilsson, Jonas A.; Gho, Yong Song; Lötvall, Jan Journal: Biomaterials Issue: Volume 102(2016) Page Start: 231 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗